Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201105403 Principal Investigator: Abboud, Camille
Title: An Open Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects with Primary Myelofibrosis, Post Essential Thrombocythemia-Myelofibrosis and Post Polycythemia Vera-Myelofibrosis who have Platelet Counts of 50 X10 9/L to 100 X10 9/L
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The primary purpose of this study is to determine the effects of ruxolitinib on spleen volume and symptoms and to learn about any of the side effects that might occur during or following treatment.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)